CIPLA THROAT NUMBING LOZENGES blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

lidocaine hydrochloride monohydrate, Quantity: 10 mg; dichlorobenzyl alcohol, Quantity: 1.2 mg; amylmetacresol, Quantity: 0.6 mg

Disponibbli minn:

Cipla Australia Pty Ltd

INN (Isem Internazzjonali):

Amylmetacresol,Dichlorobenzyl alcohol,lidocaine (lignocaine) hydrochloride monohydrate

Għamla farmaċewtika:

Lozenge

Kompożizzjoni:

Excipient Ingredients: saccharin sodium; sucrose; quinoline yellow; liquid glucose; Flavour

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

8 lozenges, 32 lozenges, 24 lozenges, 16 lozenges

Tip ta 'preskrizzjoni:

Not scheduled. Not considered by committee

Indikazzjonijiet terapewtiċi:

For the symptomatic relief of minor mouth and throat infections, including sore throat and the relief of symptoms of inflammation.

Sommarju tal-prodott:

Visual Identification: Yellow colored circular lozenges; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-02-10